Serum NGAL levels in our maintenance HD patients were approximately 10–20 fold higher compared to levels reported in healthy subjects [21, 52], but iron-chelating activity of NGAL might be partly inhibited in HD patients, since these patients are replete with exogenous iron [10] to avoid anemia (Table 1). Here, LCN2 is linked to Huntington disease.